Julian S Gangolli - Net Worth and Insider Trading
Julian S Gangolli Net Worth
The estimated net worth of Julian S Gangolli is at least $23 Million dollars as of 2024-03-29. Julian S Gangolli is the President, North America of GW Pharmaceuticals PLC and owns about 106,548 shares of GW Pharmaceuticals PLC (GWPH) stock worth over $23 Million. Julian S Gangolli is also the CVP & Pres, North America of Allergan PLC and owns about 0 shares of Allergan PLC (AGN) stock worth over $0. Details can be seen in Julian S Gangolli's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Julian S Gangolli has not made any transactions after 2019-05-10 and currently still holds the listed stock(s).
Transaction Summary of Julian S Gangolli
Julian S Gangolli Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Julian S Gangolli owns 4 companies in total, including Outlook Therapeutics Inc () , Krystal Biotech Inc () , and Revance Therapeutics Inc () among others .
Click here to see the complete history of Julian S Gangolli’s form 4 insider trades.
Insider Ownership Summary of Julian S Gangolli
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Outlook Therapeutics Inc | 2020-04-20 | director | |
Krystal Biotech Inc | 2020-06-30 | director | |
Revance Therapeutics Inc | 2016-07-01 | director | |
GW Pharmaceuticals PLC | 2019-05-10 | President & North America |
Julian S Gangolli Latest Holdings Summary
Julian S Gangolli currently owns a total of 2 stocks. Among these stocks, Julian S Gangolli owns 106,548 shares of GW Pharmaceuticals PLC (GWPH) as of May 10, 2019, with a value of $23 Million and a weighting of 100%. Julian S Gangolli also owns 0 shares of Allergan PLC (AGN) as of December 27, 2013, with a value of $0 and a weighting of 0%.
Latest Holdings of Julian S Gangolli
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GWPH | GW Pharmaceuticals PLC | 2019-05-10 | 106,548 | 218.96 | 23,329,750 |
AGN | Allergan PLC | 2013-12-27 | 0 | 193.02 | 0 |
Holding Weightings of Julian S Gangolli
Julian S Gangolli Form 4 Trading Tracker
According to the SEC Form 4 filings, Julian S Gangolli has made a total of 1 transactions in GW Pharmaceuticals PLC (GWPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in GW Pharmaceuticals PLC is the sale of 671,928 shares on May 10, 2019, which brought Julian S Gangolli around $10 Million.
According to the SEC Form 4 filings, Julian S Gangolli has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 52,500 shares on December 27, 2013, which brought Julian S Gangolli around $6 Million.
Insider Trading History of Julian S Gangolli
- 1
Julian S Gangolli Trading Performance
Julian S Gangolli Ownership Network
Ownership Network List of Julian S Gangolli
Ownership Network Relation of Julian S Gangolli
Julian S Gangolli Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Julian S Gangolli is the director of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .
Outlook Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Julian S Gangolli made no insider transaction in Outlook Therapeutics Inc (). Other recent insider transactions involving Outlook Therapeutics Inc () include a net sale of 368,671 shares made by Jeff Evanson , a net purchase of 200,000 shares made by Kurt J Hilzinger , and a net sale of 520,000 shares made by Terry Dagnon .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc () in total and bought 3,124 shares, with a net purchase of 3,124 shares. During the past 18 months, 47,558 shares of Outlook Therapeutics Inc () were sold and 16,291 shares were bought by its insiders, resulting in a net sale of 31,266 shares.
Outlook Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Julian S Gangolli Mailing Address
Above is the net worth, insider trading, and ownership report for Julian S Gangolli. You might contact Julian S Gangolli via mailing address: 4955 Baseline Avenue, Santa Ynez Ca 93460.